Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 46.75T | 45.10T | 37.15T | 31.38T | 27.21T | 29.93T |
Gross Profit | 9.50T | 9.37T | 6.31T | 5.97T | 4.83T | 5.41T |
EBITDA | 8.62T | 8.39T | 5.19T | 4.82T | 4.61T | 4.13T |
Net Income | 5.10T | 4.94T | 2.45T | 2.85T | 2.25T | 2.04T |
Balance Sheet | ||||||
Total Assets | 94.67T | 90.11T | 74.30T | 67.69T | 62.27T | 52.68T |
Cash, Cash Equivalents and Short-Term Investments | 13.88T | 14.11T | 9.23T | 8.62T | 9.32T | 5.70T |
Total Debt | 39.58T | 36.56T | 29.38T | 26.50T | 25.66T | 20.55T |
Total Liabilities | 57.82T | 54.87T | 45.04T | 40.53T | 37.98T | 31.94T |
Stockholders Equity | 35.91T | 34.22T | 28.34T | 26.25T | 23.40T | 20.06T |
Cash Flow | ||||||
Free Cash Flow | -1.60T | -842.02B | -750.76B | -107.63B | -1.04T | -4.49B |
Operating Cash Flow | 4.24T | 4.21T | 2.96T | 3.72T | 2.73T | 3.59T |
Investing Cash Flow | -4.29T | -5.00T | -1.60T | -577.50B | -4.68T | -3.15T |
Financing Cash Flow | 391.01B | 2.50T | -56.18B | -2.47T | 2.74T | 397.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $41.68B | 8.40 | 11.47% | 5.64% | 3.03% | 28.54% | |
75 Outperform | $28.24B | 26.02 | 12.22% | ― | 10.28% | -29.75% | |
74 Outperform | $1.05T | 179.16 | 9.16% | ― | 1.03% | -53.71% | |
73 Outperform | $46.27B | 6.93 | 8.88% | 1.22% | 7.76% | -14.17% | |
71 Outperform | $46.54B | 8.12 | 6.54% | 3.82% | 0.83% | -26.70% | |
70 Outperform | $227.95B | 7.45 | 13.36% | 3.61% | 1.06% | -7.05% | |
61 Neutral | AU$2.78B | 25.79 | 5.01% | 5.37% | 2.63% | -29.95% |